CASI Pharmaceuticals, Inc. (CASIF)
- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $0.11
- As of
Kresmion compiles this page from CASIF's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
CASI Pharmaceuticals, Inc. (CASIF): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 6-K filed 2026-09-02.
See the full CASIF dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for CASIF on one page. Preview it with sample data, then open it live with a free account.
Preview the CASIF dossierActive events for CASIF
- mediumEarnings below estimates
Q3-2025: Missed consensus by 62.6% - EPS $-0.67 vs $-0.412 estimate
- mediumEarnings below estimates
Q1-2025: Missed consensus by 9.8% - EPS $-0.69 vs $-0.6283 estimate
- mediumEarnings below estimates
Q2-2025: Missed consensus by 77.6% - EPS $-0.86 vs $-0.4841 estimate
- mediumEarnings below estimates
Missed consensus by 62.6% - EPS $-0.67 vs $-0.412 estimate
- mediumEarnings below estimates
Q4-2025: Missed consensus by 115.7% - EPS $-0.8 vs $-0.3708 estimate
FREE, NO ACCOUNT
Every event on CASIF, as it fires
New filings, 13F moves and cross asset events on CASIF land in the record first.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter. Other reporting quarters are linked above.
Recent SEC filings, CASIF
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 20-FSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
Going concern statement
CASIF's 20-F filed May 15, 2026 states:
Our recurring operating losses raise substantial doubt about our ability to continue as a going concern.
Read the 20-F on SEC EDGAR Every company with a going concern statement
More data on CASIF
Related tickers
Cite this data
Kresmion counts the managers it follows that reported a non-option position in CASIF on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on CASIF in the last 180 days.
Upstream: SEC EDGAR filings for CASIF
Kresmion, "CASI Pharmaceuticals, Inc. (CASIF) institutional holdings and SEC filings", data as of 2026-09-02, https://kresmion.com/research/CASIF. Upstream data: SEC EDGAR filings for CASIF.
Link to this data (HTML):
<a href="https://kresmion.com/research/CASIF">CASI Pharmaceuticals, Inc. (CASIF) institutional holdings and SEC filings (Kresmion)</a>
Writing about this? Press contact and ready-to-quote figures
Follow CASIF on a live board
Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to CASIF for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.